Addressing the Challenges of Progressive Multiple Sclerosis: Diagnosis and Management of Progressive MS - Frequently Asked Questions

Faculty respond to frequently asked questions on diagnosing and managing progressive MS.
Format: Adobe Acrobat (.pdf)
File Size: 243 KB
Released: December 4, 2019

Acknowledgements

Provided by
Purdue University Logo

Accreditation: Dawn Sinclair, Purdue University sinclaid@purdue.edu
Certificates/Credits: Heather Holley, Purdue University hholley@purdue.edu

This activity is supported by an educational grant from
Novartis Pharmaceuticals Corporation

Related Content

Concise CCO activity on selecting second-generation antipsychotics for treatment augmentation in patients with MDD and managing adverse events

Rakesh Jain, MD, MPH Physicians: maximum of 0.75 AMA PRA Category 1 Credits Released: May 7, 2020 Expired: May 6, 2021

Free slides from CCO and Rakesh Jain, MD, MPH: Expert insights on efficacy, role of antipsychotics in MDD, mitigating and manage adverse events

Rakesh Jain, MD, MPH Released: May 7, 2020

Free slides from CCO and Christoph U. Correll, MD: Expert insights on comorbidities in treatment augmentation for MDD

Christoph U. Correll, MD Released: April 13, 2020

Expert commentary on prevention and emerging treatment strategies for the COVID-19 pandemic from CCO

Daniel R. Kuritzkes, MD Released: March 19, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue